Advancements in Structural and Functional Drug Discovery of Vector-borne Diseases.
Advancements in Structural and Functional Drug Discovery of Vector-borne Diseases.
3-5 July 2024 - Saïd Business School (Oxford) & Diamond Light Source
About the event
The aim of this event is to foster collaboration between researchers involved in various aspects of drug discovery against vector-borne diseases, structural biology and biophysics.
During the event, participants will delve into various aspects of parasitology, exploring rational drug design approaches that bridge chemical research and structural sciences. The focus will include also eco-toxicology and the One Health concept, emphasizing the interconnectedness of human, animal, and environmental health.
In addition to invited and contributed talks, the event will host a number of round-table discussions, providing a platform for researchers to showcase their current work and latest findings.
For more information and registration go to the website of the event.
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
OneHealthdrugs CA21111
Title:
One Health drugs against parasitic vector borne diseases in Europe and beyond
